Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Status:
Recruiting
Trial end date:
2026-04-15
Target enrollment:
Participant gender:
Summary
This study was to compare the study drug KN060 to enoxaparin, for the prevention of blood
clotting and safety in patients undergoing total knee arthroplasty (TKA).